Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

for
Malignancy, Hematologic, Neoplasms, Hematologic,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06904066

Phase 1, Recruiting

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

for
Oncology, Myeloid Leukemia, Acute, Cancer
Location: Rochester NY, Chapel Hill NC, Winston-Salem NC,
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT06697600

Recruiting

MDR - PMCF Study for Taperloc Complete Stems

for
Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries,
Location: Plano TX
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT04028687

Recruiting

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: New York NY, Atlanta GA
Sponsor: Meryx, Inc.

Sex: All

Age: 12+

Code: NCT04872478

Phase 1, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

MCT for the Harvard/UCSF ROBIN Center

for
Glioma, Childhood Brainstem, Neuroblastoma
Location: Boston MA, San Francisco CA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 0+

Code: NCT06000787

Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting

His-Bundle Corrective Pacing in Heart Failure

for
Right Bundle-Branch Block, Heart Failure, His-bundle Pacing,
Location: New York NY, Ridgewood NJ, Burlington VT,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05265520

Recruiting

Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.

for
Immune Tolerance
Location: Palo Alto CA
Sponsor: Stephan Busque

Sex: All

Age: 18+

Code: NCT03591302

Phase 1, Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

for
COVID-19, ARDS, Human, Stem Cells, Regeneration
Location: Baltimore MD
Sponsor: MedRegen LLC

Sex: All

Age: 18+

Code: NCT04646603

Phase 2, Recruiting

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

for
Obesity, Stem Cell Transplant
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 13 - 30

Code: NCT04997473

Recruiting

Immune Tolerance Induction After Liver Transplantation

for
Liver Transplantation, Immune Tolerance,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18+

Code: NCT07269041

Phase 1, Phase 2, Recruiting

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

for
Leukemia, Acute Leukemia, Acute Lymphoid Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 6+

Code: NCT07634653

Recruiting

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

for
Leukemia, Acute, MDS
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 60+

Code: NCT03680677

Recruiting
New

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for PCOS

for
Polycystic Ovary Syndrome (PCOS), Polycystic Ovary Syndrome,
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: Female

Age: 18+

Code: NCT06143527

Phase 1, Recruiting
New

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

for
Autism
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 0+

Code: NCT05003960

Phase 1, Recruiting
New

Safety of Cultured Allogeneic Adult Umbilical-cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

for
Spinal Cord Injuries
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 0+

Code: NCT05018793

Phase 1, Recruiting
New

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for SCI

for
Spinal Cord Injuries
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 0+

Code: NCT05152290

Phase 1, Recruiting
New

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty

for
Frailty
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 0+

Code: NCT05018767

Phase 1, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial